{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:59:55Z","timestamp":1769122795747,"version":"3.49.0"},"reference-count":74,"publisher":"Georg Thieme Verlag KG","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent years, an increasing number of studies have revealed deleterious effects of aldosterone via the mineralocorticoid receptor (MR). Especially in patients with primary aldosteronism (PA) a significant higher estimated risk of developing cardiovascular comorbidities and comortalities compared to essential hypertensives was reported. As diabetes mellitus and the metabolic syndrome are one of the major contributors to cardiovascular morbidity and mortality their connection to aldosterone excess became a focus of research in PA patients. Several studies assessed the effect of PA on glucose metabolism, the prevalence of diabetes mellitus, and the effect of PA treatment on both revealing different results. Therefore, we performed an extensive literature research. This review focuses on the current knowledge of the connection between aldosterone excess, glucose homeostasis, and diabetes mellitus in patients with PA. We have highlighted this topic from a pro and contra perspective followed by a summarizing concluding remark. Additionally, we have briefly reviewed the data on possible underlying mechanisms and indicated future considerations on the possible impact of cortisol co-secretion in PA.<\/jats:p>","DOI":"10.1055\/s-0035-1565208","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T00:17:57Z","timestamp":1450138677000},"page":"987-993","source":"Crossref","is-referenced-by-count":26,"title":["Glucose Metabolism in Primary Aldosteronism"],"prefix":"10.1055","volume":"47","author":[{"given":"H.","family":"Remde","sequence":"first","affiliation":[{"name":"Clinical Endocrinology, Charit\u00e9 Campus Mitte, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Hanslik","sequence":"first","affiliation":[{"name":"Clinical Endocrinology, Charit\u00e9 Campus Mitte, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Rayes","sequence":"first","affiliation":[{"name":"Clinic for Surgery, Campus Virchow, Charit\u00e9 University Medicine Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Quinkler","sequence":"additional","affiliation":[{"name":"Endocrinology in Charlottenburg, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2015,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1530\/EJE-14-0537","article-title":"Progress in aldosteronism: A review of the prevalence of primary aldosteronism in pre-hypertension and hypertension","volume":"172","author":"G Piaditis","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Review: Diagnosis and management of primary aldosteronism","volume":"2","author":"M Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline","volume":"93","author":"J W Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00268-004-7496-z","article-title":"Long-term Follow-up after Adrenalectomy for Primary Aldosteronism","volume":"29","author":"A Meyer","year":"2005","journal-title":"World J Surg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-14-1013","article-title":"Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism","volume":"172","author":"M Weigel","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"P Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"W F Young","year":"2004","journal-title":"Surgery"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0031-1299681","article-title":"Outcomes of Adrenalectomy in Patients with Unilateral Primary Aldosteronism: A Review","volume":"44","author":"O Steichen","year":"2012","journal-title":"Horm Metab Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"G P Rossi","year":"2013","journal-title":"Hypertension"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/bjs.9744","article-title":"Systematic review of surgery and outcomes in patients with primary aldosteronism","volume":"102","author":"A Muth","year":"2015","journal-title":"Br J Surg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","article-title":"Primary aldosteronism: cardiovascular, renal and metabolic implications","volume":"19","author":"G-P Rossi","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0029-1243257","article-title":"Comorbidities in Primary Aldosteronism","volume":"42","author":"M Quinkler","year":"2010","journal-title":"Horm Metab Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism","volume":"91","author":"F Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.numecd.2009.03.007","article-title":"Metabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants","volume":"20","author":"V Ronconi","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0031-1295412","article-title":"Primary Aldosteronism and Metabolic Syndrome","volume":"44","author":"F Fallo","year":"2012","journal-title":"Horm Metab Res"},{"issue":"S 01","key":"ref16","first-page":"S62","article-title":"Diagnosis and Classification of Diabetes Mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196511182732106","article-title":"Hypertension, the Potassium Ion and Impaired Carbohydrate Tolerance","volume":"273","author":"J W Conn","year":"1965","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is Primary Aldosteronism Associated with Diabetes Mellitus? Results of the German Conn\u2019s Registry","volume":"42","author":"M Reincke","year":"2010","journal-title":"Horm Metab Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn Registry","volume":"173","author":"G Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","article-title":"Kidney impairment in primary aldosteronism","volume":"412","author":"V-C Wu","year":"2011","journal-title":"Clin Chim Acta"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: A controlled cross-sectional study","volume":"53","author":"J Matrozova","year":"2009","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc07-0525","article-title":"Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients","volume":"30","author":"G Colussi","year":"2007","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: A follow-up study","volume":"91","author":"C Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","article-title":"A possible association between primary aldosteronism and a lower b-cell function","volume":"25","author":"L M Mosso","year":"2007","journal-title":"J Hypertens"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone excess impairs first phase insulin secretion in primary aldosteronism","volume":"98","author":"E Fischer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.33549\/physiolres.930298","article-title":"Does the treatment of primary hyperaldosteronism influence glucose tolerance","volume":"52","author":"B \u0160trauch","year":"2003","journal-title":"Physiol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"G Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mce.2012.02.007","article-title":"Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients","volume":"355","author":"T A Williams","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/en.2013-1115","article-title":"Antioxidant N -Acetylcysteine Protects Pancreatic b-Cells Against Aldosterone-Induced Oxidative Stress and Apoptosis in Female db\/db Mice and Insulin-Producing MIN6 Cells","volume":"154","author":"H M Jin","year":"2013","journal-title":"Endocrinology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s00125-011-2158-9","article-title":"Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets","volume":"54","author":"J M Luther","year":"2011","journal-title":"Diabetologia"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone Suppresses Insulin Signaling Via the Downregulation of Insulin Receptor Substrate-1 in Vascular Smooth Muscle Cells","volume":"50","author":"H Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/ATVBAHA.111.240697","article-title":"Aldosterone Induces Vascular Insulin Resistance by Increasing Insulin-Like Growth Factor-1 Receptor and Hybrid Receptor","volume":"32","author":"S J Sherajee","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/ATVBAHA.113.302854","article-title":"Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors","volume":"34","author":"D Pruthi","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-012-1452-2","article-title":"Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat","volume":"372","author":"J Selvaraj","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2008-1018","article-title":"Aldosterone Inhibits Insulin-Induced Glucose Uptake by Degradation of Insulin Receptor Substrate (IRS) 1 and IRS2 via a Reactive Oxygen Species-Mediated Pathway in 3T3-L1 Adipocytes","volume":"150","author":"T Wada","year":"2009","journal-title":"Endocrinology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2009.06.030","article-title":"Impact of excess aldosterone on glucose homeostasis in adult male rat","volume":"407","author":"J Selvaraj","year":"2009","journal-title":"Clin Chim Acta"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.51.243","article-title":"Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade","volume":"51","author":"R Yamashita","year":"2014","journal-title":"Endocr J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbrc.2006.02.065","article-title":"Mineralocorticoid receptor is involved in the regulation of genes responsible for hepatic glucose production","volume":"342","author":"G Liu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.33549\/physiolres.930123","article-title":"Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus","volume":"50","author":"J Widimsk\u1ef3 Jr","year":"2001","journal-title":"Physiol Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00004872-200209000-00035","article-title":"Risk of new-onset diabetes in the losartan intervention for endpoint reduction in hypertension study","volume":"20","author":"L H Lindholm","year":"2002","journal-title":"J Hypertens"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","article-title":"Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus","volume":"342","author":"T W Gress","year":"2000","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00125-007-0803-0","article-title":"Relationship between glycated haemoglobin levels and mean glucose levels over time","volume":"50","author":"D M Nathan","year":"2007","journal-title":"Diabetologia"},{"key":"ref43","first-page":"G214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"R A DeFronzo","year":"1979","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00004872-199816070-00001","article-title":"How to measure insulin sensitivity","volume":"16","author":"E Ferrannini","year":"1998","journal-title":"J Hypertens"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"D R Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"A Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2002-030024","article-title":"Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders","volume":"89","author":"J \u0160krha","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/eje.0.1500097","article-title":"Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies","volume":"150","author":"B Ahr\u00e9n","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.1994.tb02573.x","article-title":"Increased insulin sensitivity in patients with aldosterone producing adenoma","volume":"41","author":"M Ishimori","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12224","article-title":"Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects","volume":"16","author":"R Garg","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"L Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/diab.22.7.544","article-title":"Glucose intolerance with hypokalemia: Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia","volume":"22","author":"P Gorden","year":"1973","journal-title":"Diabetes"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2337\/diab.32.2.106","article-title":"Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium","volume":"32","author":"J H Helderman","year":"1983","journal-title":"Diabetes"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/eem.11.60","article-title":"Potassium and risk of Type 2 diabetes","volume":"6","author":"R Chatterjee","year":"2011","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archinternmed.2010.362","article-title":"Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The atherosclerosis risk in communities (ARIC) study","volume":"170","author":"R Chatterjee","year":"2010","journal-title":"Arch Intern Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","article-title":"Thiazide diuretics, potassium, and the development of diabetes: A quantitative review","volume":"48","author":"A J Zillich","year":"2006","journal-title":"Hypertension"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of aldosterone on insulin sensitivity and secretion","volume":"91","author":"J M Luther","year":"2014","journal-title":"Steroids"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-5996-6-90","article-title":"The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes","volume":"6","author":"T Bruder-Nascimento","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/db12-0905","article-title":"Mineralocorticoid receptor-mediated vascular insulin resistance: An early contributor to diabetes-related vascular disease?","volume":"62","author":"S B Bender","year":"2013","journal-title":"Diabetes"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-, and proinflammatory adipokines","volume":"117","author":"C Guo","year":"2008","journal-title":"Circulation"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1006871309864","article-title":"In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess","volume":"185","author":"J Campi\u00f3n","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"T Wada","year":"2010","journal-title":"Endocrinology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"A86","DOI":"10.1016\/0002-9343(77)90883-X","article-title":"Concurrent hypercortisolism and hypermineralocorticoidism","volume":"62","author":"M J Hogan","year":"1977","journal-title":"Am J Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-10-1070","article-title":"Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism","volume":"164","author":"M Spath","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2169\/internalmedicine.42.714","article-title":"A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone","volume":"42","author":"J Adachi","year":"2003","journal-title":"Intern Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1291\/hypres.30.367","article-title":"Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion","volume":"30","author":"J Suzuki","year":"2007","journal-title":"Hypertens Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/hr.2010.18","article-title":"Sporadic solitary aldosterone-and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism","volume":"33","author":"H S Willenberg","year":"2010","journal-title":"Hypertens Res"},{"key":"ref68","first-page":"564","article-title":"Primary aldosteronism associated with subclinical Cushing syndrome","volume":"36","author":"K Fujimoto","year":"2013","journal-title":"J Endocrinol Invest."},{"key":"ref69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","article-title":"Clinicopathological features of primary aldosteronism associated with subclinical Cushing\u2019s syndrome","volume":"58","author":"K Hiraishi","year":"2011","journal-title":"Endocr J"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tem.2011.09.001","article-title":"Diabetes in cushing syndrome: basic and clinical aspects","volume":"22","author":"G Mazziotti","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"M133","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in Cushing\u2019s syndrome","volume":"173","author":"F Ferrau","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"Management of Endocrine Disease: The burden of Cushing\u2019s disease: clinical and health-related quality of life aspects","volume":"167","author":"R A Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"S 01","key":"ref73","first-page":"S107","article-title":"Long-term outcomes of laparoscopic adrenalectomy for Cushing disease","volume":"12","author":"G Conzo","year":"2014","journal-title":"2014 Spring Conf Ital Soc Endocr Surg \u2013 Ther Strateg Endocr Surg"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12020-012-9628-9","article-title":"Glucose metabolism in patients with subclinical Cushing\u2019s syndrome","volume":"41","author":"R Giordano","year":"2012","journal-title":"Endocrine"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0035-1565208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:53:40Z","timestamp":1748721220000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0035-1565208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":74,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2015,12,14]]},"published-print":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0035-1565208","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}